Hyasynth is a company headquartered in Canada.
Hyasynth engineers yeast to biosynthetically produce cannabinoids such as THC, CBD, and rare minor cannabinoids, offering a scalable and cost-effective alternative to traditional cannabis plant cultivation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.